カテゴリ： 世界, 医療/バイオ, Market Monitor Global

サル痘ウイルスワクチンのグローバル市場展望 2023年-2029年：MVA-BN、LC16、オルソポックスバック

■ 英語タイトル：Monkeypox Virus Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14437）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14437
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[サル痘ウイルスワクチンのグローバル市場展望 2023年-2029年：MVA-BN、LC16、オルソポックスバック]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のサル痘ウイルスワクチン市場規模と予測を収録しています。・世界のサル痘ウイルスワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のサル痘ウイルスワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のサル痘ウイルスワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「MVA-BN」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

サル痘ウイルスワクチンのグローバル主要企業は、Bavarian Nordic、 Sanofi Pasteur Biologics、 KM Biologics、 Yatai Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、サル痘ウイルスワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のサル痘ウイルスワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のサル痘ウイルスワクチン市場：タイプ別市場シェア、2022年
・MVA-BN、LC16、オルソポックスバック

世界のサル痘ウイルスワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のサル痘ウイルスワクチン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のサル痘ウイルスワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のサル痘ウイルスワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるサル痘ウイルスワクチンのグローバル売上、2018年-2023年
・主要企業におけるサル痘ウイルスワクチンのグローバル売上シェア、2022年
・主要企業におけるサル痘ウイルスワクチンのグローバル販売量、2018年-2023年
・主要企業におけるサル痘ウイルスワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bavarian Nordic、 Sanofi Pasteur Biologics、 KM Biologics、 Yatai Group

*************************************************************

・調査・分析レポートの概要
サル痘ウイルスワクチン市場の定義
市場セグメント
世界のサル痘ウイルスワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のサル痘ウイルスワクチン市場規模
世界のサル痘ウイルスワクチン市場規模：2022年 VS 2029年
世界のサル痘ウイルスワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのサル痘ウイルスワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のサル痘ウイルスワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：MVA-BN、LC16、オルソポックスバック
サル痘ウイルスワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
サル痘ウイルスワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別サル痘ウイルスワクチン市場規模 2022年と2029年
地域別サル痘ウイルスワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bavarian Nordic、 Sanofi Pasteur Biologics、 KM Biologics、 Yatai Group
...

This research report provides a comprehensive analysis of the Monkeypox Virus Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Monkeypox Virus Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Monkeypox Virus Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Monkeypox Virus Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Monkeypox Virus Vaccine market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Monkeypox Virus Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Monkeypox Virus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Monkeypox Virus Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Monkeypox Virus Vaccine market.
Market Overview: The report provides a comprehensive overview of the Monkeypox Virus Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., MVA-BN, LC16), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Monkeypox Virus Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Monkeypox Virus Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Monkeypox Virus Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Monkeypox Virus Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Monkeypox Virus Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Monkeypox Virus Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Monkeypox Virus Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Monkeypox Virus Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Monkeypox Virus Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
MVA-BN
LC16
OrthopoxVac
Market segment by Application
Hospital
Clinic
Others
Global Monkeypox Virus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bavarian Nordic
Sanofi Pasteur Biologics
KM Biologics
Yatai Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Virus Vaccine, market overview.
Chapter 2: Global Monkeypox Virus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Monkeypox Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Monkeypox Virus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Monkeypox Virus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monkeypox Virus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Virus Vaccine Overall Market Size
2.1 Global Monkeypox Virus Vaccine Market Size: 2022 VS 2029
2.2 Global Monkeypox Virus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Monkeypox Virus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Monkeypox Virus Vaccine Players in Global Market
3.2 Top Global Monkeypox Virus Vaccine Companies Ranked by Revenue
3.3 Global Monkeypox Virus Vaccine Revenue by Companies
3.4 Global Monkeypox Virus Vaccine Sales by Companies
3.5 Global Monkeypox Virus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Monkeypox Virus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Monkeypox Virus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Monkeypox Virus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Monkeypox Virus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Monkeypox Virus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Monkeypox Virus Vaccine Market Size Markets, 2022 & 2029
4.1.2 MVA-BN
4.1.3 LC16
4.1.4 OrthopoxVac
4.2 By Type – Global Monkeypox Virus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Monkeypox Virus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Monkeypox Virus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Monkeypox Virus Vaccine Sales & Forecasts
4.3.1 By Type – Global Monkeypox Virus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Monkeypox Virus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Monkeypox Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Monkeypox Virus Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Monkeypox Virus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Monkeypox Virus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Monkeypox Virus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Monkeypox Virus Vaccine Sales & Forecasts
5.3.1 By Application – Global Monkeypox Virus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Monkeypox Virus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Monkeypox Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Monkeypox Virus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Monkeypox Virus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Monkeypox Virus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Monkeypox Virus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Monkeypox Virus Vaccine Sales & Forecasts
6.3.1 By Region – Global Monkeypox Virus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Monkeypox Virus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Monkeypox Virus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Monkeypox Virus Vaccine Sales, 2018-2029
6.4.3 US Monkeypox Virus Vaccine Market Size, 2018-2029
6.4.4 Canada Monkeypox Virus Vaccine Market Size, 2018-2029
6.4.5 Mexico Monkeypox Virus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Monkeypox Virus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Monkeypox Virus Vaccine Sales, 2018-2029
6.5.3 Germany Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.4 France Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.5 U.K. Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.6 Italy Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.7 Russia Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Monkeypox Virus Vaccine Market Size, 2018-2029
6.5.9 Benelux Monkeypox Virus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Monkeypox Virus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Monkeypox Virus Vaccine Sales, 2018-2029
6.6.3 China Monkeypox Virus Vaccine Market Size, 2018-2029
6.6.4 Japan Monkeypox Virus Vaccine Market Size, 2018-2029
6.6.5 South Korea Monkeypox Virus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Monkeypox Virus Vaccine Market Size, 2018-2029
6.6.7 India Monkeypox Virus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Monkeypox Virus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Monkeypox Virus Vaccine Sales, 2018-2029
6.7.3 Brazil Monkeypox Virus Vaccine Market Size, 2018-2029
6.7.4 Argentina Monkeypox Virus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Monkeypox Virus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Monkeypox Virus Vaccine Sales, 2018-2029
6.8.3 Turkey Monkeypox Virus Vaccine Market Size, 2018-2029
6.8.4 Israel Monkeypox Virus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Monkeypox Virus Vaccine Market Size, 2018-2029
6.8.6 UAE Monkeypox Virus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bavarian Nordic
7.1.1 Bavarian Nordic Company Summary
7.1.2 Bavarian Nordic Business Overview
7.1.3 Bavarian Nordic Monkeypox Virus Vaccine Major Product Offerings
7.1.4 Bavarian Nordic Monkeypox Virus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Bavarian Nordic Key News & Latest Developments
7.2 Sanofi Pasteur Biologics
7.2.1 Sanofi Pasteur Biologics Company Summary
7.2.2 Sanofi Pasteur Biologics Business Overview
7.2.3 Sanofi Pasteur Biologics Monkeypox Virus Vaccine Major Product Offerings
7.2.4 Sanofi Pasteur Biologics Monkeypox Virus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Biologics Key News & Latest Developments
7.3 KM Biologics
7.3.1 KM Biologics Company Summary
7.3.2 KM Biologics Business Overview
7.3.3 KM Biologics Monkeypox Virus Vaccine Major Product Offerings
7.3.4 KM Biologics Monkeypox Virus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 KM Biologics Key News & Latest Developments
7.4 Yatai Group
7.4.1 Yatai Group Company Summary
7.4.2 Yatai Group Business Overview
7.4.3 Yatai Group Monkeypox Virus Vaccine Major Product Offerings
7.4.4 Yatai Group Monkeypox Virus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Yatai Group Key News & Latest Developments
8 Global Monkeypox Virus Vaccine Production Capacity, Analysis
8.1 Global Monkeypox Virus Vaccine Production Capacity, 2018-2029
8.2 Monkeypox Virus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Monkeypox Virus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Monkeypox Virus Vaccine Supply Chain Analysis
10.1 Monkeypox Virus Vaccine Industry Value Chain
10.2 Monkeypox Virus Vaccine Upstream Market
10.3 Monkeypox Virus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Monkeypox Virus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Monkeypox Virus Vaccine in Global Market
Table 2. Top Monkeypox Virus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Monkeypox Virus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Monkeypox Virus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Monkeypox Virus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Monkeypox Virus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Monkeypox Virus Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Monkeypox Virus Vaccine Product Type
Table 9. List of Global Tier 1 Monkeypox Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monkeypox Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Monkeypox Virus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Monkeypox Virus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Monkeypox Virus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Monkeypox Virus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Monkeypox Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Monkeypox Virus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Monkeypox Virus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Monkeypox Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Monkeypox Virus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Monkeypox Virus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Monkeypox Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Monkeypox Virus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Monkeypox Virus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Monkeypox Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Monkeypox Virus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Monkeypox Virus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Monkeypox Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Monkeypox Virus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Monkeypox Virus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Monkeypox Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Monkeypox Virus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Monkeypox Virus Vaccine Sales, (K Units), 2024-2029
Table 46. Bavarian Nordic Company Summary
Table 47. Bavarian Nordic Monkeypox Virus Vaccine Product Offerings
Table 48. Bavarian Nordic Monkeypox Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bavarian Nordic Key News & Latest Developments
Table 50. Sanofi Pasteur Biologics Company Summary
Table 51. Sanofi Pasteur Biologics Monkeypox Virus Vaccine Product Offerings
Table 52. Sanofi Pasteur Biologics Monkeypox Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sanofi Pasteur Biologics Key News & Latest Developments
Table 54. KM Biologics Company Summary
Table 55. KM Biologics Monkeypox Virus Vaccine Product Offerings
Table 56. KM Biologics Monkeypox Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. KM Biologics Key News & Latest Developments
Table 58. Yatai Group Company Summary
Table 59. Yatai Group Monkeypox Virus Vaccine Product Offerings
Table 60. Yatai Group Monkeypox Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Yatai Group Key News & Latest Developments
Table 62. Monkeypox Virus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Monkeypox Virus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Monkeypox Virus Vaccine Production by Region, 2018-2023 (K Units)
Table 65. Global Monkeypox Virus Vaccine Production by Region, 2024-2029 (K Units)
Table 66. Monkeypox Virus Vaccine Market Opportunities & Trends in Global Market
Table 67. Monkeypox Virus Vaccine Market Drivers in Global Market
Table 68. Monkeypox Virus Vaccine Market Restraints in Global Market
Table 69. Monkeypox Virus Vaccine Raw Materials
Table 70. Monkeypox Virus Vaccine Raw Materials Suppliers in Global Market
Table 71. Typical Monkeypox Virus Vaccine Downstream
Table 72. Monkeypox Virus Vaccine Downstream Clients in Global Market
Table 73. Monkeypox Virus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Monkeypox Virus Vaccine Segment by Type in 2022
Figure 2. Monkeypox Virus Vaccine Segment by Application in 2022
Figure 3. Global Monkeypox Virus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Monkeypox Virus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Monkeypox Virus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Monkeypox Virus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Monkeypox Virus Vaccine Revenue in 2022
Figure 9. By Type - Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Monkeypox Virus Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Monkeypox Virus Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Monkeypox Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Monkeypox Virus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 23. US Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 37. China Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Monkeypox Virus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Monkeypox Virus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Monkeypox Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Monkeypox Virus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Monkeypox Virus Vaccine by Region, 2022 VS 2029
Figure 54. Monkeypox Virus Vaccine Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • サル痘ウイルス核酸検出キット（蛍光PCR）の世界市場2023年：ダブルPCR検出、トリプルPCRアッセイ
  • 注射用インフルエンザワクチンのグローバル市場展望 2023年-2029年：価インフルエンザワクチン、4価インフルエンザワクチン
  • ブリスターフリーシリンジワクチンのグローバル市場展望 2023年-2029年：弱毒化生ワクチン、不活化ワクチン、mRNAワクチン、DNA組換えワクチン、その他
  • 細胞培養系インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 帯状疱疹ワクチンのグローバル市場展望 2023年-2029年：生、組換え
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14437 )"サル痘ウイルスワクチンのグローバル市場展望 2023年-2029年：MVA-BN、LC16、オルソポックスバック" (英文：Monkeypox Virus Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。